Dr. Pande has served as a member of the Sio board since March 2015. He serves as Chief Medical Advisor of PureTech Health, President of Verity BioConsulting, a drug development consulting firm, and Chief Medical Officer of Tal Medical, a clinical-stage medical device company. From 2007 to April 2014, Dr. Pande was Senior Vice President and Senior Advisor, Pharmaceutical R&D, at GlaxoSmithKline. He has also held senior roles at Pfizer R&D, Parke-Davis/Warner-Lambert and Lilly Research Laboratories. Dr. Pande is also a non-executive board member of Autifony Therapeutics and Karuna Pharmaceuticals. Dr. Pande received a Bachelor of Medicine, Bachelor of Surgery (MBBS) degree from the University of Lucknow, India, and completed his research fellowship training in psychiatry at the University of Michigan Medical School and postgraduate specialty training and psychiatry residency program at Western University.